COPS5 and neoplasm: Moreover, a highly specific small‐molecule inhibitor of Jab1/CSN5 (CSN5i‐3) was recently reported to have a large anti‐tumour therapeutic window according to recent studies that involved in vitro and in vivo tests.31, 32